Portfolio Holdings Detail for ISIN IE00BYXG2H39
| Stock Name / Fund | iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares IV Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300ZP07LMR36K1T02 |
| ETF Ticker | BTEC(USD) LSE |
| ETF Ticker | BTEK(GBP) LSE |
| ETF Ticker | 2B70(EUR) F |
| ETF Ticker | 2B70.DE(EUR) CXE |
| ETF Ticker | BTEC.LS(USD) CXE |
| ETF Ticker | BTEK.LS(GBP) CXE |
| ETF Ticker | BTEC.L(GBP) LSE |
| ETF Ticker | BTEK.L(GBP) LSE |
Holdings detail for AQST
| Stock Name | Aquestive Therapeutics Inc |
| Ticker | AQST(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US03843E1047 |
Show aggregate AQST holdings
News associated with AQST
- Oppenheimer Boosts Aquestive Therapeutics (NASDAQ:AQST) Price Target to $8.00
- Aquestive Therapeutics (NASDAQ:AQST – Get Free Report) had its price target increased by equities research analysts at Oppenheimer from $7.00 to $8.00 in a report released on Monday, Marketbeat reports. The firm currently has an “outperform” rating on the stock. Oppenheimer’s price target would indicate a potential upside of 60.64% from the company’s current price. […] - 2025-09-10 03:13:05
- Aquestive Therapeutics (NASDAQ:AQST) Shares Gap Up After Analyst Upgrade
- Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report)’s stock price gapped up prior to trading on Thursday after Lifesci Capital upgraded the stock to a strong-buy rating. The stock had previously closed at $3.95, but opened at $4.29. Aquestive Therapeutics shares last traded at $5.07, with a volume of 10,098,647 shares changing hands. A number […] - 2025-09-05 02:40:43
- XTX Topco Ltd Buys New Shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST)
- XTX Topco Ltd purchased a new stake in shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) during the first quarter, HoldingsChannel reports. The institutional investor purchased 78,522 shares of the company’s stock, valued at approximately $228,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Price […] - 2025-08-13 04:26:45
- 10,568 Shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST) Bought by Victory Capital Management Inc.
- Victory Capital Management Inc. acquired a new stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,568 shares of the company’s stock, valued at approximately $31,000. Other hedge funds also […] - 2025-08-04 05:58:52
- Cambridge Investment Research Advisors Inc. Takes $33,000 Position in Aquestive Therapeutics, Inc. (NASDAQ:AQST)
- Cambridge Investment Research Advisors Inc. bought a new stake in shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) during the first quarter, Holdings Channel.com reports. The fund bought 11,303 shares of the company’s stock, valued at approximately $33,000. A number of other institutional investors have also recently modified their holdings of the business. Deutsche […] - 2025-07-16 04:31:00
- Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Recommendation of “Buy” from Brokerages
- Shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) have been assigned an average recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat reports. Seven analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have issued ratings on the stock […] - 2025-07-09 02:49:09
- Oppenheimer Initiates Coverage on Aquestive Therapeutics (NASDAQ:AQST)
- Research analysts at Oppenheimer started coverage on shares of Aquestive Therapeutics (NASDAQ:AQST – Get Free Report) in a research report issued to clients and investors on Monday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $7.00 price target on the stock. Oppenheimer’s price objective would indicate a potential upside of 120.13% from […] - 2025-06-04 02:34:52
- Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives $10.67 Consensus PT from Brokerages
- Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has been given an average rating of “Buy” by the six brokerages that are currently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the stock in […] - 2025-05-23 03:14:53
- MetLife Investment Management LLC Buys 4,125 Shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST)
- MetLife Investment Management LLC increased its stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) by 11.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 40,221 shares of the company’s stock after purchasing an additional 4,125 shares during the quarter. MetLife Investment Management LLC’s […] - 2025-05-09 05:44:58
- Marshall Wace LLP Makes New $198,000 Investment in Aquestive Therapeutics, Inc. (NASDAQ:AQST)
- Marshall Wace LLP purchased a new stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund purchased 55,695 shares of the company’s stock, valued at approximately $198,000. Other institutional investors and hedge funds have also made changes to their positions in […] - 2025-05-06 04:44:52
- Brokerages Set Aquestive Therapeutics, Inc. (NASDAQ:AQST) Price Target at $10.67
- Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has received a consensus rating of “Buy” from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target […] - 2025-04-28 02:38:59
- ExodusPoint Capital Management LP Has $258,000 Stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST)
- ExodusPoint Capital Management LP lifted its stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) by 52.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 72,507 shares of the company’s stock after buying an additional 24,984 shares during the period. ExodusPoint […] - 2025-04-14 04:46:55
- Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Purchased by Intech Investment Management LLC
- Intech Investment Management LLC lifted its holdings in Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) by 120.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,677 shares of the company’s stock after purchasing an additional 21,645 shares during the […] - 2025-03-28 06:30:46
- Aquestive Therapeutics (NASDAQ:AQST) Given Buy Rating at HC Wainwright
- Aquestive Therapeutics (NASDAQ:AQST – Get Free Report)‘s stock had its “buy” rating restated by HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $10.00 price target on the stock. HC Wainwright’s price objective would suggest a potential upside of 278.79% from the company’s current price. HC Wainwright also issued estimates […] - 2025-03-12 04:08:57
- Short Interest in Aquestive Therapeutics, Inc. (NASDAQ:AQST) Drops By 5.9%
- Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) was the target of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 11,090,000 shares, a decrease of 5.9% from the January 15th total of 11,790,000 shares. Based on an average daily trading volume, of 1,470,000 […] - 2025-02-20 05:01:11
- Brokerages Set Aquestive Therapeutics, Inc. (NASDAQ:AQST) Target Price at $11.00
- Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Free Report) has been given an average rating of “Buy” by the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 […] - 2025-02-12 04:10:43
- China Universal Asset Management Co. Ltd. Makes New $69,000 Investment in Aquestive Therapeutics, Inc. (NASDAQ:AQST)
- China Universal Asset Management Co. Ltd. acquired a new position in Aquestive Therapeutics, Inc. (NASDAQ:AQST – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 19,333 shares of the company’s stock, valued at approximately $69,000. A number of other […] - 2025-02-04 06:53:03
iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) AQST holdings
| Date | Number of AQST Shares Held | Base Market Value of AQST Shares | Local Market Value of AQST Shares | Change in AQST Shares Held | Change in AQST Base Value | Current Price per AQST Share Held | Previous Price per AQST Share Held |
|---|
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of AQST by Blackrock for IE00BYXG2H39
Show aggregate share trades of AQST| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-06 | BUY | 609 | 5.970 | 5.980 | 5.979 | USD 3,641 | 3.41 |
| 2025-10-03 | BUY | 1,421 | 5.800 | 5.930 | 5.917 | USD 8,408 | 3.40 |
| 2025-10-02 | BUY | 203 | 5.770 | 5.925 | 5.910 | USD 1,200 | 3.39 |
| 2025-09-30 | BUY | 406 | 5.590 | 5.690 | 5.680 | USD 2,306 | 3.36 |
| 2025-09-26 | BUY | 406 | 5.990 | 6.430 | 6.386 | USD 2,593 | 3.33 |
| 2025-09-25 | BUY | 406 | 5.260 | 5.510 | 5.485 | USD 2,227 | 3.32 |
| 2025-09-24 | BUY | 9,558 | 5.420 | 5.440 | 5.438 | USD 51,976 | 3.31 |
| 2025-09-18 | BUY | 178 | 4.940 | 4.960 | 4.958 | USD 883 | 3.30 |
| 2025-09-17 | BUY | 534 | 4.830 | 4.970 | 4.956 | USD 2,647 | 3.29 |
| 2025-09-11 | SELL | -176 | 4.950 | 5.010 | 5.004 | USD -881 | 3.25  Loss of -308 on sale |
| 2025-09-10 | BUY | 352 | 4.880 | 5.030 | 5.015 | USD 1,765 | 3.24 |
| 2025-09-05 | SELL | -175 | 5.420 | 5.480 | 5.474 | USD -958 | 3.21 Loss of -396 on sale |
| 2025-08-29 | SELL | -534 | 3.770 | 3.870 | 3.860 | USD -2,061 | 3.19 Loss of -360 on sale |
| 2025-08-27 | BUY | 354 | 3.850 | 4.131 | 4.103 | USD 1,452 | 3.18 |
| 2025-08-26 | SELL | -177 | 3.900 | 4.080 | 4.062 | USD -719 | 3.17 Loss of -157 on sale |
| 2025-08-25 | BUY | 177 | 3.860 | 3.985 | 3.972 | USD 703 | 3.17 |
| 2025-08-20 | SELL | -700 | 3.880 | 3.950 | 3.943 | USD -2,760 | 3.16 Loss of -548 on sale |
| 2025-08-18 | BUY | 348 | 4.180 | 4.255 | 4.248 | USD 1,478 | 3.15 |
| 2025-08-08 | SELL | -348 | 3.900 | 3.990 | 3.981 | USD -1,385 | 3.12 Loss of -298 on sale |
| 2025-08-05 | BUY | 174 | 3.940 | 4.065 | 4.053 | USD 705 | 3.11 |
| 2025-08-01 | SELL | -519 | 3.820 | 3.905 | 3.896 | USD -2,022 | 3.10 Loss of -415 on sale |
| 2025-07-30 | BUY | 692 | 3.920 | 4.100 | 4.082 | USD 2,825 | 3.09 |
| 2025-07-17 | SELL | -348 | 4.370 | 4.415 | 4.410 | USD -1,535 | 3.01 Loss of -486 on sale |
| 2025-07-11 | SELL | -1,408 | 4.010 | 4.190 | 4.172 | USD -5,874 | 2.98 Loss of -1,673 on sale |
| 2025-07-07 | BUY | 528 | 3.700 | 3.800 | 3.790 | USD 2,001 | 2.96 |
| 2025-07-02 | BUY | 9,680 | 3.680 | 3.685 | 3.684 | USD 35,666 | 2.94 |
| 2025-06-25 | BUY | 352 | 3.250 | 3.300 | 3.295 | USD 1,160 | 2.93 |
| 2025-06-20 | BUY | 8,071 | 3.250 | 3.460 | 3.439 | USD 27,756 | 2.92 |
| 2025-06-11 | BUY | 298 | 3.410 | 3.620 | 3.599 | USD 1,073 | 2.89 |
| 2025-06-10 | BUY | 298 | 3.580 | 3.670 | 3.661 | USD 1,091 | 2.88 |
| 2025-06-04 | SELL | -149 | 3.410 | 3.615 | 3.595 | USD -536 | 2.86 Loss of -110 on sale |
| 2025-04-23 | BUY | 149 | 2.820 | 2.970 | 2.955 | USD 440 | 2.93 |
| 2025-04-10 | SELL | -1,192 | 2.420 | 2.515 | 2.506 | USD -2,987 | 2.99  Profit of 576 on sale |
| 2025-04-08 | SELL | -149 | 2.370 | 2.690 | 2.658 | USD -396 | 3.00 Profit of 52 on sale |
| 2025-04-07 | SELL | -149 | 2.620 | 2.740 | 2.728 | USD -406 | 3.01 Profit of 42 on sale |
| 2025-04-04 | SELL | -745 | 2.710 | 2.825 | 2.814 | USD -2,096 | 3.02 Profit of 151 on sale |
| 2025-04-01 | BUY | 596 | 2.860 | 3.050 | 3.031 | USD 1,806 | 3.02 |
| 2025-03-31 | SELL | -447 | 2.900 | 2.970 | 2.963 | USD -1,324 | 3.02 Profit of 25 on sale |
| 2025-03-14 | SELL | -2,400 | 2.840 | 2.900 | 2.894 | USD -6,946 | 3.01 Profit of 285 on sale |
| 2025-03-07 | SELL | -300 | 2.650 | 2.695 | 2.690 | USD -807 | 3.05 Profit of 108 on sale |
| 2025-03-04 | SELL | -150 | 2.730 | 2.740 | 2.739 | USD -411 | 3.08 Profit of 50 on sale |
| 2025-02-25 | BUY | 300 | 2.795 | 2.990 | 2.971 | USD 891 | 3.12 |
| 2025-02-19 | SELL | -150 | 3.030 | 3.160 | 3.147 | USD -472 | 3.14 Loss of -2 on sale |
| 2025-02-13 | BUY | 450 | 3.470 | 3.630 | 3.614 | USD 1,626 | 3.11 |
| 2025-02-12 | BUY | 150 | 3.390 | 3.415 | 3.412 | USD 512 | 3.10 |
| 2025-02-11 | BUY | 596 | 2.970 | 3.000 | 2.997 | USD 1,786 | 3.10 |
| 2025-01-17 | BUY | 596 | 3.100 | 3.140 | 3.136 | USD 1,869 | 3.19 |
| 2025-01-16 | BUY | 596 | 3.090 | 3.300 | 3.279 | USD 1,954 | 3.20 |
| 2025-01-10 | SELL | -298 | 3.080 | 3.100 | 3.098 | USD -923 | 3.31 Profit of 63 on sale |
| 2025-01-08 | SELL | -596 | 3.130 | 3.250 | 3.238 | USD -1,930 | 3.67 Profit of 257 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of AQST
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 3,495,696 | 15,525 | 7,504,361 | 46.6% |
| 2025-09-18 | 328,240 | 500 | 484,597 | 67.7% |
| 2025-09-17 | 227,018 | 244 | 382,704 | 59.3% |
| 2025-09-16 | 284,957 | 0 | 499,223 | 57.1% |
| 2025-09-15 | 445,635 | 600 | 680,626 | 65.5% |
| 2025-09-12 | 674,558 | 0 | 1,301,627 | 51.8% |
| 2025-09-11 | 159,694 | 1,733 | 312,299 | 51.1% |
| 2025-09-10 | 198,357 | 0 | 455,994 | 43.5% |
| 2025-09-09 | 246,772 | 8,500 | 716,954 | 34.4% |
| 2025-09-08 | 704,367 | 52 | 1,793,843 | 39.3% |
| 2025-09-05 | 1,096,645 | 12,592 | 2,785,905 | 39.4% |
| 2025-09-04 | 2,169,363 | 12,652 | 6,362,832 | 34.1% |
| 2025-09-03 | 254,044 | 0 | 568,803 | 44.7% |
| 2025-09-02 | 172,168 | 698 | 515,130 | 33.4% |
| 2025-08-29 | 210,135 | 0 | 452,942 | 46.4% |
| 2025-08-28 | 215,308 | 0 | 504,868 | 42.6% |
| 2025-08-27 | 656,151 | 0 | 1,192,793 | 55.0% |
| 2025-08-26 | 305,414 | 0 | 652,567 | 46.8% |
| 2025-08-25 | 286,426 | 0 | 547,468 | 52.3% |
| 2025-08-22 | 216,024 | 2,961 | 464,861 | 46.5% |
| 2025-08-21 | 281,524 | 0 | 651,151 | 43.2% |
| 2025-08-20 | 307,694 | 60 | 688,186 | 44.7% |
| 2025-08-19 | 372,028 | 29 | 972,244 | 38.3% |
| 2025-08-18 | 282,078 | 4,122 | 613,902 | 45.9% |
| 2025-08-15 | 285,991 | 850 | 602,259 | 47.5% |
| 2025-08-14 | 2,466,294 | 1,903 | 3,665,321 | 67.3% |
| 2025-08-13 | 184,142 | 0 | 550,490 | 33.5% |
| 2025-08-12 | 488,764 | 1,977 | 761,594 | 64.2% |
| 2025-08-11 | 144,539 | 2,080 | 410,891 | 35.2% |
| 2025-08-08 | 142,714 | 7,733 | 329,901 | 43.3% |
| 2025-08-07 | 115,035 | 800 | 204,046 | 56.4% |
| 2025-08-06 | 187,834 | 0 | 309,831 | 60.6% |
| 2025-08-05 | 145,297 | 2,893 | 295,248 | 49.2% |
| 2025-08-04 | 124,795 | 0 | 227,294 | 54.9% |
| 2025-08-01 | 148,495 | 0 | 293,110 | 50.7% |
| 2025-07-31 | 83,718 | 0 | 306,543 | 27.3% |
| 2025-07-30 | 105,074 | 8,490 | 283,961 | 37.0% |
| 2025-07-29 | 135,045 | 3,035 | 416,567 | 32.4% |
| 2025-07-28 | 114,296 | 0 | 444,107 | 25.7% |
| 2025-07-25 | 125,193 | 342 | 314,620 | 39.8% |
| 2025-07-24 | 97,125 | 0 | 275,404 | 35.3% |
| 2025-07-23 | 257,681 | 11,421 | 633,250 | 40.7% |
| 2025-07-22 | 238,300 | 208 | 521,282 | 45.7% |
| 2025-07-21 | 238,286 | 949 | 511,323 | 46.6% |
| 2025-07-18 | 446,783 | 9,160 | 819,128 | 54.5% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Note: All information is provided as is without warranty and should be used for indicative purposes only.
You should independently check data before making any investment decision.
This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.
Copyright Market Footprint Ltd. Privacy Policy